Becker's Healthcare September 23, 2021
Hannah Mitchell

Verily, Alphabet’s life sciences arm, is looking to untangle itself from Google to prepare for a future outside its parent company and a potential IPO, according to a Sept. 21 Insider report.

Verily was created in 2015 inside Google X’s research group. Alphabet’s holding option gave Verily an opportunity to gain some freedom and separate itself from Google’s operations.

Five things to know:

  1. Verily is planning to gain independence from Google’s technology in a project known internally as Flywheel, according to the report. Verily and Google are working together on the project.
  2. Many of Verily’s products rely on Google’s cloud. Verily is focused on transitioning from Google’s internal cloud to a public version available to other businesses....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Pharma / Biotech, Technology, Trends
Gilead bets on Xilio cancer drug as biotech restructures
Pfizer shifts creative to Publicis in latest marketing move
Boundless Bio’s ‘BOLD’ IPO Reels In $100M for a New Kind of Cancer Drug
Joseph La Barge On The Challenges Of Advancing Gene Therapy, Finding The Right Support
Exact Sciences' posts positive data for its capsule-on-a-string test for esophageal cancer

Share This Article